-
3861“…We applied CeVICA to engineer antibodies against the Receptor Binding Domain (RBD) of the SARS-CoV-2 spike proteins and identified >800 predicted binder families. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3862por Starr, Tyler N., Greaney, Allison J., Addetia, Amin, Hannon, William W., Choudhary, Manish C., Dingens, Adam S., Li, Jonathan Z., Bloom, Jesse D.“…Here we map how all mutations to SARS-CoV-2’s receptor-binding domain (RBD) affect binding by the antibodies in Regeneron’s REGN-COV2 cocktail and Eli Lilly’s LY-CoV016. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3863por Hassan, Sk. Sarif, Ghosh, Shinjini, Attrish, Diksha, Choudhury, Pabitra Pal, Aljabali, Alaa A. A., Uhal, Bruce D., Lundstrom, Kenneth, Rezaei, Nima, Uversky, Vladimir N., Seyran, Murat, Pizzol, Damiano, Adadi, Parise, Soares, Antonio, El-Aziz, Tarek Mohamed Abd, Kandimalla, Ramesh, Tambuwala, Murtaza M., Azad, Gajendra Kumar, Sherchan, Samendra P., Baetas-da-Cruz, Wagner, Takayama, Kazuo, Serrano-Aroca, Ángel, Chauhan, Gaurav, Palu, Giorgio, Brufsky, Adam M.“…The spike (S) protein receptor-binding domain (RBD) of SARS-CoV-2 binds to the three sub-domains viz. amino acids (aa) 22–42, aa 79–84, and aa 330–393 of ACE2 on human cells to initiate entry. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3864“…A receptor-binding domain (RBD) in VP1u is responsible for the specific targeting and uptake of the virus exclusively into cells of the erythroid lineage in the bone marrow. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3865por Devarasetti, Phani Kumar, Rajasekhar, Liza, Baisya, Ritasman, Sreejitha, K. S., Vardhan, Yerram Keerthi“…Neutralizing antibodies (NAb) present in CP generated in response to SARS-CoV-2 infection directed against the receptor-binding domain (RBD) of the spike protein are considered to play main role in viral clearance. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3866por Pérez de la Lastra, José Manuel, Asensio-Calavia, Patricia, González-Acosta, Sergio, Baca-González, Victoria, Morales-delaNuez, Antonio“…The peptides were modeled and subjected to docking analysis with the region binding domain (RBD) region of the SARS-CoV-2 Spike protein. The appearance of multiple forms of cathelicidins verifies the complex microbial challenges encountered by these species. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3867por Ohgitani, Eriko, Shin-Ya, Masaharu, Ichitani, Masaki, Kobayashi, Makoto, Takihara, Takanobu, Kawamoto, Masaya, Kinugasa, Hitoshi, Mazda, Osam“…EGCG, TSA, and TFDG significantly inhibited interaction between recombinant ACE2 and RBD of S protein. These results suggest potential usefulness of tea in prevention of person-to-person transmission of the novel coronavirus.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3868“…The same effects were observed when the receptor binding domain (RBD) of SARS‐CoV‐2—a currently tested epitope for mRNA vaccination—was used. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3869“…Eculizumab was discontinued, and repeat vaccination with two doses of an alternative EUA mRNA vaccine led to circulating IgG specific for the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) protein, and to detectable S-specific T cell responses. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3870por Fiorino, Fabio, Sicuranza, Anna, Ciabattini, Annalisa, Santoni, Adele, Pastore, Gabiria, Simoncelli, Martina, Polvere, Jacopo, Galimberti, Sara, Auddino, Stefano, Baratè, Claudia, Montagnani, Francesca, Sammartano, Vincenzo, Bocchia, Monica, Medaglini, Donata“…Here, we show that 76% of MF patients develop spike-specific IgG after the second mRNA SARS-CoV-2 vaccine dose, but the response has a slower kinetics compared to healthy subjects, suggesting a reduced capability of their immune system to promptly react to vaccination. A reduced ACE2/RBD binding inhibition activity of spike-specific antibodies was also observed, especially in ruxolitinib-treated patients. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3871por Henderson, Rory, Edwards, Robert J., Mansouri, Katayoun, Janowska, Katarzyna, Stalls, Victoria, Gobeil, Sophie, Kopp, Megan, Li, Dapeng, Parks, Rob, Hsu, Allen L., Borgnia, Mario J., Haynes, Barton F., Acharya, Priyamvada“…Based on this analysis, we developed two soluble ectodomain constructs for SARS-CoV-2 S-protein in which the highly immunogenic and mobile receptor binding domain (RBD) is either locked in the all-RBDs ‘down’ position or adopts ‘up’ state conformations more readily than wild-type S-protein. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3872por Yadav, Pragya D., Mendiratta, Sanjeev Kumar, Mohandas, Sreelekshmy, Singh, Arun K., Abraham, Priya, Shete, Anita, Bandyopadhyay, Sanjay, Kumar, Sanjay, Parikh, Aashini, Kalita, Pankaj, Sharma, Vibhuti, Pandya, Hardik, Patel, Chirag G., Patel, Mihir, Soni, Swagat, Giri, Suresh, Jain, Mukul“…The mAbs were designed to have reduced immune effector functions and increased circulation half-life. mAbs showed good binding affinities to non-competing epitopes on RBD of SARS-CoV-2 spike protein and were found neutralizing SARS-CoV-2 variants B.1, B.1.1.7, B.1.351, B.1.617.2, and B.1.617.2 AY.1 in vitro. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3873por Zhu, Shiyi, Ju, Zizhao, Wu, Ping, Liu, Fengtao, Ge, Jingjie, Zhang, Huiwei, Lu, Jiaying, Li, Ling, Wang, Min, Jiang, Jiehui, Wang, Jian, Zuo, Chuantao“…In PDPNI, the clinical and imaging data of patients diagnosed with Parkinsonian syndromes and Idiopathic rapid eye movement sleep behavior disorder (RBD) were longitudinally followed every two years, aiming to identify progression biomarkers of Parkinsonian syndromes through functional imaging modalities including FDG-PET, DAT-PET imaging, ASL MRI, and fMRI, as well as the treatment conditions, clinical symptoms, and clinical assessment results of patients. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3874por Kong, Lingkai, Meng, Jieru, Tian, Wenyue, Liu, Jiazheng, Hu, Xueping, Jiang, Zhi-Hong, Zhang, Wei, Li, Yanzhong, Bai, Li-Ping“…Quinoxalines 4ca and 4ad inhibited viral entry of SARS-CoV-2 spike pseudoviruses into HEK-293T-ACE2(h) host cells as dual blockers of both human ACE2 receptor and viral spike RBD with IC(50) values of 19.70 and 21.28 μM, respectively. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3875por González Viacava, Myriam Belén, Varese, Augusto, Mazzitelli, Ignacio, Lanari, Laura, Ávila, Lucía, García Vampa, María Julia, Geffner, Jorge, Cascone, Osvaldo, Dokmetjian, José Christian, de Roodt, Adolfo Rafael, Fingermann, Matías“…In this study we analyzed the biological activity (viral neutralization or NtAb) and immunochemical properties of hyperimmune horses’ sera (HHS) obtained during initial immunization (I) and posterior re-immunization (R) cycles using the RBD domain of the SARS-CoV-2 spike protein as antigen. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3876“…In this work, the main conformations and interactions between the receptor-binding domain (RBD) of spike glycoprotein gp120 of HIV-1 and the IgG1-b12 mAb are studied. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3877por Addetia, Amin, Park, Young-Jun, Starr, Tyler, Greaney, Allison J., Sprouse, Kaitlin R, Bowen, John E., Tiles, Sasha W., Van Voorhis, Wesley C., Bloom, Jesse D., Corti, Davide, Walls, Alexandra C., Veesler, David“…The SARS-CoV-2 receptor-binding domain (RBD) E406W mutation abrogates neutralization mediated by the REGEN-CoV therapeutic monoclonal antibody (mAb) COVID-19 cocktail and the cilgavimab (AZD1061) mAb. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3878Publicado 2021“…Our proof-of-concept results with humanized monoclonal anti-SARS-CoV-2 Spike receptor-binding domain (RBD) IgG demonstrate that the thermo-photonic technology can detect and quantify antibody concentrations within the clinically relevant range and with a limit of detection of [Formula: see text] /ml. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3879por Zaffina, Salvatore, Piano Mortari, Eva, Di Prinzio, Reparata Rosa, Cappa, Marco, Novelli, Antonio, Agolini, Emanuele, Raponi, Massimiliano, Dallapiccola, Bruno, Locatelli, Franco, Perno, Carlo Federico, Carsetti, Rita“…Ten days after Ad26.COV2 administration, S- and RBD-specific antibodies and high-affinity memory B cells increased significantly to values close to those observed in Health Care Worker controls.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3880“…The most cited sleep disorders in PD included insomnia, restless legs syndrome (RLS), rapid eye movement (REM), sleep behavior disorders (RBD), excessive daytime sleepiness (EDS) and sleep disordered breathing (SDB), which can appear alone or several at the same time. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto